Keros Therapeutics

KROS

Capitalización de mercado USD 225 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
76	76 MetLife Investment Management Whippany, New Jersey	USD 178 k	–	–	–
77	77 Jump Financial Chicago, Illinois	USD 165 k	-USD 390 k	-34,993	-69%
78	78 EJF Capital Arlington, Virginia	USD 160 k	–	–	–
79	79 JP Morgan Chase New York	USD 160 k	-USD 257 k	-23,056	-61%
80	80 nVerses Capital Wellington, Florida	USD 140 k	+USD 146 k	+13,124	Nuevas
81	81 Engineers Gate Manager New York	USD 131 k	-USD 48.8 k	-4,380	-26%
82	82 PDT Partners New York	USD 122 k	-USD 238 k	-21,339	-65%
83	83 Point72 Asset Management Stamford, Connecticut	USD 111 k	-USD 1.1 M	-98,622	-90%
84	84 American Financial Group Cincinnati, Ohio	USD 108 k	–	–	–
85	85 Arax Advisory Partners Denver, Colorado	USD 108 k	+USD 108 k	+9,658	+2,483%
86	86 New York State Common Retirement Fund Albany, New York	USD 97.5 k	–	–	–
87	87 Citigroup New York	USD 96.5 k	+USD 75.8 k	+6,807	+308%
88	88 Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong	USD 91.1 k	-USD 59.9 k	-5,380	-39%
89	89 Legal & General Group London, United Kingdom	USD 90 k	+USD 64.5 k	+5,789	+221%
90	90 Vanguard Global Advisers Malvern, Pennsylvania	USD 85 k	-USD 87 k	-7,810	-50%
91	91 Police & Firemen's Retirement System of New Jersey Trenton, New Jersey	USD 82.4 k	–	–	–
92	92 Nisa Investment Advisors St. Louis, Missouri	USD 42.7 k	+USD 20.1 k	+1,800	+82%
93	93 Royal Bank of Canada Toronto, Ontario, Canada	USD 34 k	-USD 18.9 k	-1,693	-35%
94	94 China Universal Asset Management Company Shanghai, China	USD 33.7 k	-USD 25.1 k	-2,256	-42%
95	95 IFP Advisors Tampa, Florida	USD 32.2 k	+USD 1.79 k	+161	+6%
96	96 Ameritas Investment Partners Lincoln, Nebraska	USD 25.4 k	–	–	–
97	97 Osaic Holdings Scottsdale, Arizona	USD 22 k	+USD 11	+1	+0%
98	98 Tower Research Capital (TRC) New York	USD 21 k	-USD 8.15 k	-732	-27%
99	99 Zurich Cantonal Bank Zurich, Switzerland	USD 15.1 k	+USD 7.98 k	+716	+102%
100	100 UBS AM Chicago, Illinois	USD 14.6 k	–	–	–

Keros Therapeutics KROS Capitalización de mercado USD 225 M

Keros Therapeutics

KROS

Capitalización de mercado USD 225 M